Serum fructosamine a better indicator than glycated hemoglobin for monitoring gestational diabetes mellitus

被引:12
作者
Ayyappan, S. [1 ]
Philips, Sachu [1 ]
Kumar, C. Kishore [3 ]
Vaithiyanandane, V. [2 ]
Sasikala, C. [4 ,5 ]
机构
[1] Vivekanandha Dent Coll Women, Dept Biochem, Tirchengodu, Namakkal, India
[2] Vivekanandha Dent Coll Women, Dept Physiol, Tirchengodu, Namakkal, India
[3] Sri Lakshmi Narayana Inst Med Sci, Dept Physiol, Pondicherry, India
[4] Sri Lakshmi Narayana Inst Med Sci, Dept Pharmacol, Pondicherry, India
[5] Bharath Univ, Madras, Tamil Nadu, India
关键词
Fructosamine; gestational diabetes mellitus; glycated hemoglobin;
D O I
10.4103/0975-7406.155786
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gestational Diabetes mellitus is the condition of glucose intolerance that begins during pregnancy which is associated with both fetal and maternal complications. The measurement of serum fructosamine and glycated hemoglobin in normal and diabetic pregnancy used to investigate the influence of maternal and gestational age on concentrations of glycated proteins in serum and used to evaluate the patients treatment. This study was done to measure the level of serum fructosamine and Glycated hemoglobin (HbA1c) in Gestational Diabetes mellitus (GDM) patients and to compare with pregnant women without diabetes and healthy non-pregnant adults, to determine the pattern of change in serum fructosamine, influence of serum fructosamine and HbA1c values and to evaluate the efficacy of patients treatment. In this study the level of fructosamine was positively correlated to HbA1c during 2 (nd) trimesters of gestational period, implying that the level of fructosamine can be used to screen Gestational diabetes mellitus. Correlation of glycated hemoglobin values with serum fructosamine measurements in the accurate determination of glycaemic control provides confirmation of the utility of fructosamine measurement.
引用
收藏
页码:S32 / S34
页数:3
相关论文
共 7 条
[1]  
*AM DIAB ASS, 1986, DIABETES CARE, V9, P430
[2]  
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS15
[3]   Biological variation of glycated hemoglobin - Implications for diabetes screening and monitoring [J].
Kilpatrick, ES ;
Maylor, PW ;
Keevil, BG .
DIABETES CARE, 1998, 21 (02) :261-264
[4]   Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis [J].
Macdonald, David R. ;
Hanson, Alison M. ;
Holland, Martin R. ;
Singh, Baldev M. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 :421-425
[5]  
Makris Konstantinos, 2011, J Diabetes Sci Technol, V5, P1572
[6]  
*/* S 81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081
[7]  
Sultanpur CM, 2010, INT J PHARM SCI REV, V3, P119